These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

642 related items for PubMed ID: 16269957

  • 1. The Felodipine Event Reduction (FEVER) Study: a randomized long-term placebo-controlled trial in Chinese hypertensive patients.
    Liu L, Zhang Y, Liu G, Li W, Zhang X, Zanchetti A, FEVER Study Group.
    J Hypertens; 2005 Dec; 23(12):2157-72. PubMed ID: 16269957
    [Abstract] [Full Text] [Related]

  • 2. [The FEVER (Felodipine EVEnt Reduction) trial; a randomised, double-blind, placebo-controlled trial in Chinese hypertensive patients].
    Soucek M, Plachý M.
    Vnitr Lek; 2007 Jan; 53(1):63-70. PubMed ID: 17472017
    [Abstract] [Full Text] [Related]

  • 3. Higher cardiovascular risk and impaired benefit of antihypertensive treatment in hypertensive patients requiring additional drugs on top of randomized therapy: is adding drugs always beneficial?
    Zhang Y, Zhang X, Liu L, Wang Y, Tang X, Zanchetti A, FEVER Study Group.
    J Hypertens; 2012 Nov; 30(11):2202-12. PubMed ID: 22990352
    [Abstract] [Full Text] [Related]

  • 4. Pharmacological interventions for hypertension in children.
    Chaturvedi S, Lipszyc DH, Licht C, Craig JC, Parekh R.
    Evid Based Child Health; 2014 Sep; 9(3):498-580. PubMed ID: 25236305
    [Abstract] [Full Text] [Related]

  • 5. Cochrane in context: pharmacological interventions for hypertension in children.
    Chaturvedi S, Lipszyc DH, Licht C, Craig JC, Parekh RS.
    Evid Based Child Health; 2014 Sep; 9(3):581-3. PubMed ID: 25236306
    [Abstract] [Full Text] [Related]

  • 6. Is a systolic blood pressure target <140 mmHg indicated in all hypertensives? Subgroup analyses of findings from the randomized FEVER trial.
    Zhang Y, Zhang X, Liu L, Zanchetti A, FEVER Study Group.
    Eur Heart J; 2011 Jun; 32(12):1500-8. PubMed ID: 21345850
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pharmacological interventions for hypertension in children.
    Chaturvedi S, Lipszyc DH, Licht C, Craig JC, Parekh R.
    Cochrane Database Syst Rev; 2014 Feb 01; 2014(2):CD008117. PubMed ID: 24488616
    [Abstract] [Full Text] [Related]

  • 9. The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial.
    Lithell H, Hansson L, Skoog I, Elmfeldt D, Hofman A, Olofsson B, Trenkwalder P, Zanchetti A, SCOPE Study Group.
    J Hypertens; 2003 May 01; 21(5):875-86. PubMed ID: 12714861
    [Abstract] [Full Text] [Related]

  • 10. Comparison of the antihypertensive effects of the fixed dose combination enalapril 10 mg/nitrendipine 20 mg vs losartan 50 mg/hydrochlorothiazide 12.5 mg, assessed by 24-h ambulatory blood pressure monitoring, in essential hypertensive patients.
    de la Sierra A, Gil-Extremera B, Calvo C, Campo C, García-Puig J, Márquez E, Oliván J, Roca Cusachs A, Sanz de Castro S, Pontes C, Delgadillo J.
    J Hum Hypertens; 2004 Mar 01; 18(3):215-22. PubMed ID: 14973517
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM, Malacco E, Khder Y, Kandra A, Bönner G, Heintz D.
    Clin Ther; 2005 May 01; 27(5):578-87. PubMed ID: 15978306
    [Abstract] [Full Text] [Related]

  • 13. A factorial study of combination hypertension treatment with metoprolol succinate extended release and felodipine extended release results of the Metoprolol Succinate-Felodipine Antihypertension Combination Trial (M-FACT).
    Frishman WH, Hainer JW, Sugg J, M-FACT Study Group.
    Am J Hypertens; 2006 Apr 01; 19(4):388-95. PubMed ID: 16580575
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Ambulatory 24-h blood pressure assessment of the felodipine-metoprolol combination versus amlodipine in mild to moderate hypertension. Lorraine General Physician Investigators Group.
    Zannad F, Boivin JM.
    J Hypertens; 1999 Jul 01; 17(7):1023-32. PubMed ID: 10419077
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Antihypertensive efficacy and tolerability of two fixed-dose combinations of valsartan and hydrochlorothiazide compared with valsartan monotherapy in patients with stage 2 or 3 systolic hypertension: an 8-week, randomized, double-blind, parallel-group trial.
    Lacourcière Y, Poirier L, Hebert D, Assouline L, Stolt P, Rehel B, Khder Y.
    Clin Ther; 2005 Jul 01; 27(7):1013-21. PubMed ID: 16154480
    [Abstract] [Full Text] [Related]

  • 19. Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial.
    Black HR, Elliott WJ, Grandits G, Grambsch P, Lucente T, White WB, Neaton JD, Grimm RH, Hansson L, Lacourciere Y, Muller J, Sleight P, Weber MA, Williams G, Wittes J, Zanchetti A, Anders RJ, CONVINCE Research Group.
    JAMA; 2005 Jul 01; 289(16):2073-82. PubMed ID: 12709465
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.